Skip to search formSkip to main contentSkip to account menu

Lactobacillus reuteri 100000000 UNT Chewable Tablet

Known as: Lactobacillus reuteri 100 Million Cells Chewable Tablet, Lactobacillus reuteri 100 Million UNT Chewable Tablet, Lactobacillus reuteri 100,000,000 UNT Chewable Tablet 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundObesity is characterized by increased fat mass and is associated with the development of insulin resistance syndrome… 
Review
2018
Review
2018
Lactobacillus reuteri DSM17938 effectively reduces crying in breastfed infants with colic; these are the most definitive… 
Highly Cited
2012
Highly Cited
2012
Background/Objectives:The percentage of hypercholesterolemic individuals not reaching their LDL-cholesterol (LDL-C) goal remains… 
Highly Cited
2012
Highly Cited
2012
Background  Intestinal microbiota manipulation, one of the pathogenetic components of inflammatory bowel disease (IBD), has… 
Highly Cited
2012
Highly Cited
2012
Objective To investigate whether the specific strains of Lactobacillus reuteri modulates the metabolic syndrome in Apoe−/− mice… 
Highly Cited
2011
Highly Cited
2011
Several studies have reported limited or no reduction in serum cholesterol in response to probiotic formulations. Recently… 
Highly Cited
2007
Highly Cited
2007
Highly Cited
2006
Highly Cited
2006
Objective. Previous studies have suggested that lactobacilli-derived probiotics in dairy products may affect oral ecology, but… 
Highly Cited
2005
Highly Cited
2005
BackgroundShort term illnesses, usually caused by respiratory or gastrointestinal diseases are disruptive to productivity and… 
1992
1992
A high-frequency transformation system was developed forLactobacillus reuteri with the electroporation technique. With this…